News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by radus on Friday June 11, 2021 @09:59AM (#27473404)
This would likely lead to a pharmaceutical landscape that is more like the supplements industry -- no thank you.
[ Parent | on HN ]

There are no comments on this comment yet.